Literature DB >> 2386958

Establishment and characterization of human renal cancer and normal kidney cell lines.

T Ebert1, N H Bander, C L Finstad, R D Ramsawak, L J Old.   

Abstract

We have reviewed our laboratory's efforts to establish continuous human renal cancer cell lines. During the 16-year period of 1972 through 1987, 498 successive attempts resulted in establishment of 63 renal cancer cell lines. Of these lines, 46 were derived from primary kidney tumors and 17 from metastatic sites (lung, brain, bone, and lymph node). Forty-three of these lines have been characterized with regard to morphology, growth kinetics, anchorage-independent growth, tumorigenicity in athymic nude mice, and expression of kidney cell surface antigens. These results were compared with data from primary short term cultures of normal kidney epithelium. The overall success rate of establishing continuous renal cancer cell lines was 12.7%. In general, no significant difference in success was noted based on whether the specimen was derived from a primary or a metastatic lesion. However, all successfully established lines were derived from tumors exhibiting clinically "aggressive" behavior. All cell lines expressed proximal tubular cell differentiation antigens. Significant morphological heterogeneity was observed among normal kidney as well as kidney cancer cell lines in vitro. No significant difference in doubling time was found between cell lines of renal cancer and passage 1 cultures of normal kidney epithelium. Twenty-one of 30 (70%) lines assayed formed clones on soft agar and 26 of 33 (79%) lines grew in athymic mice. Among the 25 lines which were assayed for both soft agar growth and tumorigenicity in nude mice, this pair of phenotypic traits were concordant in 17 lines (60%). Four lines (16%) grew on agar but not in mice, while four other lines (16%) failed to grow in agar but were tumorigenic in mice.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2386958

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  45 in total

1.  Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma.

Authors:  Raju R Raval; Kah Weng Lau; Maxine G B Tran; Heidi M Sowter; Stefano J Mandriota; Ji-Liang Li; Christopher W Pugh; Patrick H Maxwell; Adrian L Harris; Peter J Ratcliffe
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

2.  Regulation of the expression of aminopeptidase A, aminopeptidase N/CD13 and dipeptidylpeptidase IV/CD26 in renal carcinoma cells and renal tubular epithelial cells by cytokines and cAMP-increasing mediators.

Authors:  A Kehlen; B Göhring; J Langner; D Riemann
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

3.  Pretargeted immuno-positron emission tomography imaging of carcinoembryonic antigen-expressing tumors with a bispecific antibody and a 68Ga- and 18F-labeled hapten peptide in mice with human tumor xenografts.

Authors:  Rafke Schoffelen; Robert M Sharkey; David M Goldenberg; Gerben Franssen; William J McBride; Edmund A Rossi; Chien-Hsing Chang; Peter Laverman; Jonathan A Disselhorst; Annemarie Eek; Winette T A van der Graaf; Wim J G Oyen; Otto C Boerman
Journal:  Mol Cancer Ther       Date:  2010-03-30       Impact factor: 6.261

4.  Ultrastructural appearance and cytoskeletal architecture of the clear, chromophilic, and chromophobe types of human renal cell carcinoma in vitro.

Authors:  C D Gerharz; R Moll; S Störkel; U Ramp; W Thoenes; H E Gabbert
Journal:  Am J Pathol       Date:  1993-03       Impact factor: 4.307

Review 5.  Choosing The Right Animal Model for Renal Cancer Research.

Authors:  Paweł Sobczuk; Anna Brodziak; Mohammed Imran Khan; Stuti Chhabra; Michał Fiedorowicz; Marlena Wełniak-Kamińska; Kamil Synoradzki; Ewa Bartnik; Agnieszka Cudnoch-Jędrzejewska; Anna M Czarnecka
Journal:  Transl Oncol       Date:  2020-02-22       Impact factor: 4.243

6.  Gene microarray analysis of human renal cell carcinoma: the effects of HDAC inhibition and retinoid treatment.

Authors:  Trisha S Tavares; David Nanus; Ximing J Yang; Lorraine J Gudas
Journal:  Cancer Biol Ther       Date:  2008-10-09       Impact factor: 4.742

7.  Establishment and characterization of two divergent cell lines derived from a human chromophobe renal cell carcinoma.

Authors:  C D Gerharz; R Moll; S Störkel; U Ramp; B Hildebrandt; G Molsberger; P Koldovsky; H E Gabbert
Journal:  Am J Pathol       Date:  1995-04       Impact factor: 4.307

8.  Suppression of renal cell carcinoma growth by inhibition of Notch signaling in vitro and in vivo.

Authors:  Jonas Sjölund; Martin Johansson; Sugata Manna; Carl Norin; Alexander Pietras; Siv Beckman; Elise Nilsson; Börje Ljungberg; Håkan Axelson
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

9.  Gas6 and the receptor tyrosine kinase Axl in clear cell renal cell carcinoma.

Authors:  Anna Gustafsson; Anna-Karin Boström; Börje Ljungberg; Håkan Axelson; Björn Dahlbäck
Journal:  PLoS One       Date:  2009-10-30       Impact factor: 3.240

10.  Human monoclonal antibodies targeting carbonic anhydrase IX for the molecular imaging of hypoxic regions in solid tumours.

Authors:  J K J Ahlskog; C Schliemann; J Mårlind; U Qureshi; A Ammar; R B Pedley; D Neri
Journal:  Br J Cancer       Date:  2009-07-21       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.